Placebo-only-controlled versus active-controlled trials of new drugs for nine common life-threatening diseases
Sarah Sorscher, Azza AbuDagga, Sammy Almashat, Michael A Carome, Sidney M Wolfe Health Research Group, Public Citizen, Washington, DC, USA Purpose: The Food and Drug Administration (FDA) permits investigators to withhold active interventions from human subjects randomly assigned to control groups in...
Main Authors: | Sorscher S, AbuDagga A, Almashat S, Carome MA, Wolfe SM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-04-01
|
Series: | Open Access Journal of Clinical Trials |
Subjects: | |
Online Access: | https://www.dovepress.com/placebo-only-controlled-versus-active-controlled-trials-of-new-drugs-peer-reviewed-article-OAJCT |
Similar Items
-
An audit of the approval letters issued by Drugs Controller General of India to Ethics Committees in India
by: Shruti S Bhide, et al.
Published: (2016-01-01) -
To be respectable doctors and researchers, there is only one way: to be respectable
by: Díaz Rodríguez Israel
Published: (2010-06-01) -
Ethics reporting practices in clinical research publications: A review of four Indian journals
by: Mahesh N Belhekar, et al.
Published: (2014-01-01) -
Globalization of Clinical Research and Assessment of Global Access to Treatments Approved between 2006-2015
by: Escandon, Rafael Duncan
Published: (2019) -
Development and Use of Gene Therapy Orphan Drugs—Ethical Needs for a Broader Cooperation Between the Pharmaceutical Industry and Society
by: Sandor Kerpel-Fronius, et al.
Published: (2020-12-01)